Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

NCT00809510 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00809510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00809510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2009
Completion date
Not reported
Enrollment
63 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease